| |
MESSAGE _ENGLISH VERSION_
|
|
| |
The
Management Board of Movie Games S.A.., seated in Warsaw ["Issuer" or
"Company"], with reference to the ESPI current report number 17/2025 dated
April 3, 2025, announces to the public that on April 9, 2025 in the
evening hours, it signed a cooperation agreement with Johnson Winter
Slatter ["JWS"], an Australian law firm.Prior
to signing the aforementioned agreement, the Issuer held consultations
with JWS during which the materials collected by the Company concerning
the premises indicating potential infringement of the Issuer's
intellectual property rights and the execution of acts that may bear the
characteristics of unfair competition were discussed. Based on these, the
potential scope of work and activities that JWS may undertake for the
Company in the context of Australian law was outlined.Prior
to signing the aforementioned agreement, the Issuer held consultations
with JSW, which involved a discussion of materials collected by the
Company regarding indications of potential infringement of the Issuer's
intellectual property rights and the execution of acts that may bear the
characteristics of unfair competition. Based on them, the potential scope
was outlined of the work and activities that JWS may undertake for the
Company in the context of Australian law.The
general activities around the Drug Dealer Simulator IP on the Australian
side will involve, among others, Sophie Dawson, Partner at JWS law firm,
whose experience focuses on copyright enforcement for entities such as:
Epic Games, Take-Two/Rockstar, Sony Music Entertainment, or Samsung's
dispute against Apple. The participation of Ms. Dawson is a guarantee that
any action taken will remain in accordance with the principles of
Australian law and practice applied to IP protection cases in the area of
video games.The
Company also indicates that it will strive for an amicable conclusion of
the activities in a manner that satisfies all parties involved, taking
into consideration compliance with existing laws, including the principles
of fair competition, and with regard to market practices, in order to
reach a lasting, constructive agreement and secure the interests of both
investors and other market participants. The Company also emphasizes that
its goal is not to prevent the sale or development of the Schedule 1 game.In
order to avoid doubt, the Management Board also points out that all
decisions and courses of actions aimed at protecting the Issuer's IP are
taken solely by the Company, while the Byterunners studio, responsible for
the production of games related to the DDS IP, is not involved in the
discussions or legal steps taken.The
remuneration of JWS will not affect the Company's current financial
situation due to its variant nature, depending on the results of the
cooperation.The
Issuer shall inform about further significant details in future current
reports.
|
|
|
RB: Informacje dotyczące Schedule 1 oraz działań podejmowanych przez Emitenta
